Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B is a paper indexed in PICO Portal from OpenAlex.
How many citations does Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B have?
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B has 43 citations in the OpenAlex counts PICO Portal stores.
When was Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B published?
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B has 2020 year in the PICO Portal index.
What is the open-access status of Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B?
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B has green oa status in the PICO Portal index.
What is the DOI of Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B?
The DOI for Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B is on the source record.
What is the PMID of Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B?
The PMID for Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B is on the source record.
What is the OpenAlex record for Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B?
The OpenAlex for Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B is on the source record.